China National Medicines Corporation Ltd.
600511
Rank in Stocks
#4917
China National Medicines Corporation Ltd., in conjunction with its various... China National Medicines Corporation Ltd., in conjunction with its various operating entities, is a prominent player in the distribution of pharmaceutical goods across China. The enterprise's scope extends to the production and commercialization of innovative as well as pre-existing drug formulations. Additionally, it markets both traditional Chinese patent remedies and modern Western medications, alongside a range of medical apparatus. Complementing these activities, the firm delivers warehousing solutions and acts as an agent for import and export transactions. Its diverse clientele encompasses hospitals, retail pharmacies, and other healthcare organizations. Established in 1999, the company maintains its principal office in Beijing, China.
Share Price
$3.96
Market Cap
$2.99B
Change (1 day)
0.52%
Change (1 year)
-1.48%
Country
CN
Trade China National Medicines Corporation Ltd. (600511)
Category
Healthcare
P/B ratio for China National Medicines Corporation Ltd. (600511)
P/B ratio as of October 2026 TTM: 1.09
According to China National Medicines Corporation Ltd. latest financial reports and stock price the company's current price-to-book ratio (TTM) is 1.09. At the end of 2023 the company had a P/B ratio of 1.39.
P/B ratio history for China National Medicines Corporation Ltd. from 2000 to 2026
P/B ratio at the end of each year
| Year | P/B Ratio | Change |
|---|---|---|
| 2026 (TTM) | 1.09 | -27.82% |
| 2024 | 1.51 | 8.76% |
| 2023 | 1.39 | -6.41% |
| 2022 | 1.48 | -20.45% |
| 2021 | 1.86 | -42.74% |
| 2020 | 3.25 | 64.75% |
| 2019 | 1.97 | 6.56% |
| 2018 | 1.85 | -26.85% |
| 2017 | 2.53 | -57.27% |
| 2016 | 5.93 | -1.18% |
| 2015 | 6.00 | 0.14% |
| 2014 | 5.99 | 39.72% |
| 2013 | 4.29 | 10.23% |
| 2012 | 3.89 | 0.73% |
| 2011 | 3.86 | -57.60% |
| 2010 | 9.10 | -22.52% |
| 2009 | 11.75 | 42.73% |
| 2008 | 8.23 | -30.44% |
| 2007 | 11.83 | 185.53% |
| 2006 | 4.14 | 221.37% |
| 2005 | 1.29 | -8.00% |
| 2004 | 1.40 | -27.55% |
| 2003 | 1.93 | -31.22% |
| 2002 | 2.81 | -68.47% |
| 2001 | 8.92 | -7.43% |
| 2000 | 9.64 | 0.00% |
P/B ratio for similar companies or competitors
| Company | P/B Ratio | P/B Ratio Difference | Country |
|---|---|---|---|
| -27.3394 | -2,608.43% |
US
|
|
| - | - |
US
|
|
| -20.2798 | -1,960.70% |
US
|
|
| - | - |
US
|
|
| 6.4701 | 493.64% |
AU
|
